ATHN

Eptacog Beta Efficacy in Children and Adolescents with Hemophilia A or B and Inhibitors: Subset Analysis Suggests Improved Caregiver Capacity to Assess Bleeding Episode Resolution with Subject Age

Author(s):

Guy Young, Steven W Pipe, Cedric Hermans, Manuel Carcao, Giancarlo Castaman, Joanna A Davis, Jonathan M Ducore, Amy L Dunn, Miguel A Escobar, Janna Journeycake, Osman Khan, Johnny Mahlangu, Shannon Meeks, Ismail Haroon Mitha, Claude Negrier, Ulrike Nowak-Gattl, Michael Recht, Tammuella Chrisentery-Singleton, Oleksandra Stasyshyn, Kateryna V Vilchevska, Laura Villarreal Martinez, Michael Wang, Jerzy Windyga, W Allan Alexander, Ahmad Al-Sabbagh, Daniel Bonzo, Christopher Macie, Ian S Mitchell, Thomas A Wilkinson, Amy D Shapiro
Publication:
Blood
Date:
November 23, 2021
Topics:
Children, Hemophilia, Inhibitors

Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A

Author(s):

Lindsey A George, Paul E Monahan, Elaine Eyster, Spencer K Sullivan, Margaret V Ragni, Stacy E Croteau, John EJ Rasko, Michael Recht, Benjamin J Samelson-Jones, Amy MacDougall, Kristen Jaworski, Robert Noble, Marla Curran, Klaudia Kuranda, Federico Mingozzi, Tiffany Chang, Kathleen Z Reape, Xavier M Anguela, Katherine A High
Publication:
New England Journal of Medicine
Date:
November 18, 2021
Topics:
Gene therapy, Hemophilia, Vector dose

Can’t find what you’re looking for?
Please contact support@athn.org for assistance.